KR20230143372A - A chip that mimics organs - Google Patents

Abstract

The present invention relates to an organ simulating chip structure and a method of using the same, comprising: one or more insert modules in which cells are cultured; It includes a chip capable of inserting and arranging the insert module, wherein the insert module is inserted into the chip to form a chip, and the chip is an upper fluid channel, a lower fluid channel, and an upper fluid capable of adjusting the cross-sectional area of the upper fluid channel. An organ simulating chip structure comprising a channel flow rate control unit, forming an organ simulating chip in which an organ is simulated, and co-culturing the organ simulating chip to form the multi-organ microfluidic chip structure, and a living organism using the same. It relates to a method of testing the pharmacokinetic behavior of the drug under test within the lumen and organs of the organ.

Description

A chip that mimics organs}

The present invention relates to an organ simulation chip, comprising: one or more insert modules, each of which has cells cultured; It includes a chip capable of inserting and arranging the insert module, wherein the insert module is inserted into the chip to form a chip, and the chip is an upper fluid channel, a lower fluid channel, and an upper fluid capable of adjusting the cross-sectional area of the upper fluid channel. An organ simulating chip structure comprising a channel flow rate control unit, forming an organ simulating chip in which an organ is simulated, and co-culturing the organ simulating chip to form the multi-organ microfluidic chip structure, and a living organism using the same. It relates to a method of testing the pharmacokinetic behavior of the drug under test within the lumen and organs of the organ.

Developing new drugs requires enormous costs and a long time, but the success rate is very low, less than 10%. To solve this problem, organ-on-a-chip research is actively underway. ¹ Organ chips have the great advantage of being able to replace human tissue without animal testing. Many organ chips are being developed and tested, and biomimetic multi-organ tissue chips that can simulate the absorption, distribution, metabolism, and excretion processes in the body after drug administration are also being developed. ^{2, 3} Using these multi-organ tissue chips, the intestines, It is easy to develop new drugs because it is possible to predict changes that occur in organs due to drugs through the liver and kidneys. ⁴ In addition, a biomimetic multi-organ tissue chip can induce a specific disease and predict and analyze the effect of a drug on the disease by using the absorption, distribution, metabolism, and excretion characteristics of the drug in the body. However, biomimetic multi-organ tissue chips require a common culture medium to maintain the unique functions of multiple organs similar to those in the body, so the technical difficulty is higher than single-organ tissue chip manufacturing. This problem can be solved by cultivating single organ tissues independently on inserts and then integrating the cultured inserts of each organ tissue onto one integrated chip to manufacture a multi-organ tissue chip that can perform drug testing. You can.

On the surface of organs in the living body, there are epithelial cells that come into direct contact with food and digestive juices entering the body, and components absorbed through the epithelial cells pass through the endothelial cells formed inside the organ and then move through the blood to other organs such as the liver and kidneys. and/or undergo distribution, metabolism, and excretion processes. The lumen where epithelial cells, such as intestines, liver, and kidneys, come into contact with, and the inside of organs where endothelial cells come into contact, form different environments, and in particular, different types of fluids flow. For example, food, digestive juices, etc. exist in the lumen of the small intestine, and blood flows through the side where the inner endothelial cells of the small intestine come into contact.

However, the passages through which fluids flow on both sides not only have completely different chemical environments, but also completely different physical conditions. In addition, this phenomenon also differs between individuals. For example, in patients with high blood pressure, fluid flow is active in the lumen and the cross-sectional area of the passage is wide, but the cross-sectional area of blood vessels inside the organ is small, so blood moves very slowly compared to the general population. Due to these behavioral characteristics, the absorption, distribution, metabolism, and excretion characteristics of a specific test drug may show different characteristics compared to normal people.

Furthermore, depending on the type of organ, there may be a structure with fine blood vessels flowing inside the organ. For example, the glomeruli and tubules of the kidney are distributed with blood vessels whose cross-sectional area is very small compared to other tissues.

As above, an organ simulation chip that is more similar to an in vivo organ can be provided by adjusting the cross-sectional area of the fluid passage inside the organ according to the characteristics of each individual and/or organ tissue.

Korean registered patent 10-1744663 (registered on 2017.06.01.) “Stomach-intestinal-liver biomimetic microchip” Korean Patent Publication No. 10-2018-0040407 (published on April 20, 2018) “Manufacturing of a pump-less microfluidic skin chip that simulates skin tissue and blood vessels and multi-cell culture method”

M. Rothbauer et al., Micromachines (Basel), 2021, 12. S. Ishida, Drug Metab Pharmacokinet, 2018, 33, 49-54. S. Fowler et al., Lab Chip, 2020, 20, 446-467. M. J. Wilmer et al., Trends in biotechnology, 2016, 34, 156-170. Wu et al. BioMed Eng OnLine (2020) 19:9, https://doi.org/10.1186/s12938-020-0752-0

The present invention co-cultivates epithelial cells and endothelial cells of human organs in pairs to determine the pharmacokinetic behavior of drugs such as absorption, distribution, metabolism, and excretion through organs, thereby determining the efficacy and side effects of new drugs without undergoing preclinical or clinical trials. The purpose is to provide a long-term simulation chip to verify.

In addition, the present invention aims to provide an organ simulation chip designed to differently control the flow rate through each cell layer because the shear stress of fluid applied to organ epithelial cells and endothelial cells (vascular cells) is different in the human body. do.

In order to achieve the above object, the present inventors formed two types of fluid channels in an organ simulation chip and formed a flow rate control unit (3) in the upper fluid channel corresponding to the endothelial cells, so that the flow rate can be adjusted for each organ tissue, and patients with high blood pressure can control the flow rate. Even when the cross-sectional area of blood vessels is small, the absorption, distribution, metabolism, and excretion behavior of the drug under test can be tested more accurately.

In the present invention, there is no particular limitation on the method of controlling the flow rate, and the cross-sectional area of the upper fluid channel can be adjusted by pressing downward on one side of the elastic chip frame in contact with the elastic upper fluid channel.

According to one embodiment of the present invention, a screw hole is formed in the chip frame 21 on the upper channel pattern layer 22 of a flexible material in which a fluid channel is formed, and an adjustment screw 3 is inserted into the screw hole and tightened. By adjusting the cross-sectional area of the upper fluid channel 232 in such a way that a specific part of the upper fluid channel 232 and/or a specific part of the chip frame 21 moves downward, the upper fluid channel 232 and the lower fluid channel 242 ) can be made different. One or more adjustment screws may be formed only on one side where the second culture medium chamber is located, and one or more adjustment screws may be formed on both one side where the second culture medium chamber is located and the other side where the second culture medium outlet is located.

According to another embodiment of the present invention, a hole is formed in a chip frame on an upper channel pattern layer of a flexible material in which a fluid channel is formed, and one or more weights (e.g., unit weights such as weights) are placed inside the hole to allow the upper fluid to flow. By adjusting the cross-sectional area of the upper fluid channel in such a way that a specific part of the channel 232 and/or a specific part of the chip frame 21 moves downward, the flow rate of the upper fluid channel 232 and the lower fluid channel 242 is varied. You can make it. It is preferable to use one or more unit weights as the weight. The cross-sectional area and flow rate of the upper fluid channel 232 can be adjusted by increasing the number of unit weights or adding heavier unit weights. As a type of flow rate control unit (3), one or more holes for inserting the weight may be formed only on one side where the second culture fluid chamber is located, and/or on both one side where the second culture fluid chamber is located and the other side where the second culture fluid outlet is located. Each hole can be formed to insert one or more weights.

According to another embodiment of the present invention, a permanent magnet is installed below the upper fluid channel 232 and the corresponding upper fluid channel 232, that is, a specific portion and/or chip of the upper fluid channel 232. An electromagnet is installed in a specific part of the frame 21, and the magnetic force of the electromagnet is adjusted by applying or not applying strong or weak electricity to the electromagnet as needed. The cross-sectional area of the upper fluid channel 232 can be adjusted to control the flow rate. . As a type of flow rate control unit (3), one or more electromagnets may be formed only on one side where the second culture fluid chamber is located, and/or one or more electromagnets may be formed on both one side where the second culture fluid chamber is located and the other side where the second culture fluid outlet is located. can do.

According to another specific example of the present invention, a hole is formed in a specific part of the chip frame 21 as a type of flow rate control unit 3, a plurality of locking protrusions are formed on the inner peripheral surface of the formed hole, and then a certain height is placed in the hole. The cross-section of the upper fluid channel 232 can be adjusted by positioning the pressing member and then pressing the pressing member deeply into the hole so that it is caught on a stop at a specific height. Accordingly, the cross section of the upper fluid channel 232 can be adjusted. The flow rate can be adjusted. As a type of flow rate control unit (3), one or more holes having a plurality of locking protrusions formed on the inner circumference and a pressing member located inside the hole may be formed only on one side where the second culture medium chamber is located, and/or the second culture medium chamber may be formed at least one hole. One or more can be formed on both the one side where the second culture medium outlet is located and the other side where the second culture medium outlet is located.

As described above, the flow rate control unit 3 can be formed in various shapes and/or methods, and the specific examples presented above are merely illustrative, and the flow rate control unit of the present invention is not limited thereto, as is commonly known in the technical field to which the present invention pertains. It is self-evident to those who have the knowledge of

In addition, the present invention provides a chip that simulates human organs by using a porous membrane to culture endothelial cells and epithelial cells on both sides of the porous membrane and applying shear stress to them.

The flow of fluid flowing through the fluid channel in the organ simulation chip of the present invention can be formed using a device such as a pump, and preferably, the organ simulation chip can be tilted at a specific angle using gravity to fluidize the organ without applying additional power. Not only can it create a flow, but there is no need to use a pipe connecting the pump and the chip, preventing infection due to the inflow of air bubbles or contamination through the pipe.

The structure of the organ simulation chip according to one embodiment of the present invention is as follows.

A chip (2) is made by stacking the substrate (25), lower channel pattern layer (24), middle separation pattern layer (23), upper channel pattern layer (22), and chip frame (21) in that order.

The fluid flow was created using a gravity-based system.

The medium (or first culture medium) 240 provided to the lower fluid channel exits from the first culture medium chamber 241 through the lower fluid channel 242 to the first culture medium outlet 243 on the opposite side.

The medium (or second culture medium) 230 provided to the upper fluid channel comes out of the second culture medium chamber 231 through the upper fluid channel 232 to the second culture medium outlet 233 on the opposite side.

When the medium flows through the upper fluid channel, fluid flows through the upper fluid channel connection hole (13) in the insert.

The medium flowing from the first culture medium chamber 241 through the lower fluid channel 242 supplies nutrients to the cells seeded on the bottom of the porous membrane 112 of the insert 1.

The medium flowing from the second culture chamber 231 through the upper fluid channel 232 supplies nutrients to the cells seeded on the porous membrane 112 of the insert 1.

The upper fluid channel flow rate controller (3) controls the flow rate by adjusting the cross-sectional area of the upper fluid channel (232).

There is no particular limitation on the material of the substrate, and any material that does not cause a chemical reaction with the culture medium flowing through the lower fluid channel or the substance to be tested can be used. Preferably, glass material can be used.

The first culture medium chamber (241), the lower fluid channel (242), the first culture medium outlet (243), the second culture medium chamber (231), the upper fluid channel (232), and the second culture medium outlet (233) are the culture medium or test object. There is no particular limitation as long as it is a material that does not react with the substance, but it can preferably be made of PDMS material using a metal mold.

The chip frame 21 is not particularly limited as long as it is made of a material that does not react with the culture medium or the material to be tested, but is preferably made of polycarbonate or polystyrene.

The middle separation pattern layer 23 is located between the upper channel pattern layer 22 and the lower channel pattern layer 24 and functions to separate the two layers, but is not an essential component.

In addition, the lower channel pattern layer 24 and the upper channel pattern layer 22 are not formed from separate plates, but it is also possible to form the upper fluid channel 232, lower fluid channel 242, etc. on a single plate. .

In addition, the lower channel pattern layer 24, the middle separation pattern layer 23, and the upper channel pattern layer 22 are not formed from separate plates, but the upper fluid channel 232 and the lower fluid channel 242 are formed from a single plate. ), etc. are also possible.

In addition, the lower channel pattern layer 24, the middle channel pattern layer 23, the upper channel pattern layer 22, and the chip frame 21 are not formed of separate plates, but the upper fluid channel 232 is formed on a single plate. , it is also possible to form a lower fluid channel 242, etc.

It is obvious to those skilled in the art that the above division of layers is only for the convenience of chip manufacturing and is not essential.

Attach a porous membrane (112) to the insert (1), and insert an O-ring (12) between the insert (1) and the chip (2) to prevent water leakage. Cells are attached and cultured on both the top and bottom of the porous membrane 112. There is no particular limitation on the coupling method between the insert (1) and the insert coupling portion (26) of the chip (2), but it can be press-fitted or screw-fitted.

The organ simulation chip of the present invention can be used as a chip to simulate various organs, including the kidney, liver, stomach, small intestine, large intestine, and lung.

The present invention relates to an organ simulation chip structure,

One or more inserts (1) modules, each with cells cultured; and

Includes a chip capable of inserting and placing the insert (1) module,

The plurality of insert (1) modules are inserted into the chip to form an organ simulation chip,

The organ simulation chip includes an upper fluid channel 232, a lower fluid channel 242, and an upper fluid channel flow rate controller 3 capable of adjusting the cross-sectional area of the upper fluid channel 232,

It relates to an organ simulating chip structure, wherein the organ simulating chip structure is formed by co-culturing the organ simulating chip.

In addition, the present invention is that the organ simulating chip structure is

A substrate 25, a lower channel pattern layer 24 laminated on the substrate 25, an upper channel pattern layer 22 laminated on the lower channel pattern layer 24, and on the upper channel pattern layer 22. Formed to include a stacked chip frame (21),

First culture medium chamber 241; a second culture chamber (231); One or more insert coupling portions (26) that are downwardly recessed with their upper sides open so that each of the one or more insert (1) modules can be inserted; First culture outlet (243); second culture outlet (233);

The first culture medium chamber 241 to enable movement of the first culture medium 240 between the one or more insert cell culture chambers 111 and the first culture medium outlet 243. It includes a lower fluid channel 242 connecting the one or more insert cell culture chambers 111 and the first culture outlet 243,

The second culture medium chamber 231 to enable movement of the second culture medium 230 between the second culture medium chamber 231 and the one or more insert cell culture chambers 111 and the second culture medium outlet 233. It includes an upper fluid channel (232) connecting the one or more insert cell culture chambers (111) and the second culture outlet (233),

The insert 1 is formed in a vertical direction through the chip frame 21, the upper channel pattern layer 22, and the lower channel pattern layer 24, and an insert cell culture chamber 111 is formed therein. , a porous membrane 112 is formed on one side of the insert cell culture chamber 111, and epithelial cells and endothelial cells are cultured on both surfaces of the porous membrane 112, respectively,

The upper fluid channel flow rate control unit 3 is formed on the chip frame 21 and controls the flow rate of the upper fluid channel 232 by adjusting the cross-sectional area of the upper fluid channel 232. Long-term simulation chip structure. It's about.

In addition, the present invention is that the organ simulating chip structure is

(a) one or more inserts (1) that simulate the same type of organ in the module; or

(B) It relates to an organ simulation chip structure in which different types of organs are simulated in the one or more modules of the insert (1).

Additionally, the present invention relates to a long-term simulating chip structure in which the chip frame 21 is formed of an elastic material.

In addition, the present invention relates to an organ simulation chip structure in which the upper fluid channel flow rate control unit 3 includes a screw, a weight, or an elastic body.

In addition, the present invention relates to an organ simulation chip structure, wherein the lower fluid channel 242 simulates the lumen of the organ, and the upper fluid channel 232 simulates the inside of the organ.

In addition, the present invention is one in which the components and amounts of the medium supplied to each of the one or more insert (1) modules are individually adjusted in consideration of the culture requirements for each cell cultured in each of the one or more insert (1) modules, It is about a long-term simulation chip structure.

In addition, the present invention relates to a method for testing the pharmacokinetic behavior of a drug to be tested using an organ simulating chip structure,

The long-term simulation chip structure is

One or more inserts (1) module in which cells are cultured; and

Includes a chip capable of inserting and placing the insert module,

The insert module is combined with the chip to form an organ simulation chip,

The organ simulation chip includes an upper fluid channel 232, a lower fluid channel 242, and an upper fluid channel flow rate controller 3 capable of adjusting the cross-sectional area of the upper fluid channel 232,

Different fluids flow through the upper fluid channel 232 and the lower fluid channel 242, respectively.

The upper fluid channel 232 relates to a method of testing the pharmacokinetic behavior of a drug to be tested, characterized in that the flow rate of the fluid can be adjusted by adjusting the cross-sectional area with the upper fluid channel flow rate controller 3 according to conditions.

In addition, the present invention provides an organ simulation chip structure in the above method.

A substrate 25, a lower channel pattern layer 24 laminated on the substrate 25, an upper channel pattern layer 22 laminated on the lower channel pattern layer 24, and on the upper channel pattern layer 22. Formed to include a stacked chip frame (21),

First culture medium chamber 241; a second culture chamber (231); One or more insert coupling portions (26) that are downwardly recessed with their upper sides open so that each of the one or more insert (1) modules can be inserted; First culture outlet (243); second culture outlet (233);

The first culture medium chamber 241 to enable movement of the first culture medium 240 between the one or more insert cell culture chambers 111 and the first culture medium outlet 243. It includes a lower fluid channel 242 connecting the one or more insert cell culture chambers 111 and the first culture outlet 243,

The second culture medium chamber 231 to enable movement of the second culture medium 230 between the second culture medium chamber 231 and the one or more insert cell culture chambers 111 and the second culture medium outlet 233. It includes an upper fluid channel (232) connecting the one or more insert cell culture chambers (111) and the second culture outlet (233),

The insert 1 is formed in a vertical direction through the chip frame 21, the upper channel pattern layer 22, and the lower channel pattern layer 24, and an insert cell culture chamber 111 is formed therein. , a porous membrane 112 is formed on one side of the insert cell culture chamber 111, and epithelial cells and endothelial cells are cultured on both surfaces of the porous membrane 112, respectively,

The upper fluid channel flow rate control unit 3 is formed on the chip frame 21 and controls the flow rate of the upper fluid channel 232 by adjusting the cross-sectional area of the upper fluid channel 232. It relates to methods for testing pharmacokinetic behavior.

As an example of a pharmacokinetic behavior test, in order to determine the excretory function of the proximal tubule tissue during pharmacokinetic behavior, the evaluation of the drug excretory function, which absorbs drugs from endothelial cells and excretes them to the outside from outer epithelial cells, is performed by comparing the administered drug concentration and the excreted drug concentration. Measure and determine the ratio.

The organ simulation chip of the present invention simulates the epithelium and endothelium of an organ, and can simulate an environment more similar to organ tissue in a living body by appropriately adjusting the cross-sectional area of the fluid channel on the endothelium side as needed.

In addition, the organ simulation chip of the present invention can adjust the cross-sectional area of the fluid channel in a simple manner according to the organ to be simulated and/or a specific disease such as high blood pressure, so that the pharmacokinetics of the drug to be tested for each organ and/or disease can be better understood. It can be tested accurately.

1A and 1B are side schematic diagrams of a biological tissue simulation chip. Figure 1A is a single organ tissue chip, and Figure 1B is a multi-organ tissue chip.
Figures 2a and 2b show the insert mounted on an organ tissue chip. On the left is a plan view of the lower channel pattern layer, the middle separation pattern layer, the upper channel pattern layer, and the chip frame, in order from the bottom. Figure 2a shows an insert mounted on a single organ tissue chip, and Figure 2b shows an insert mounted on a multi-organ tissue chip.
Figure 3 shows a state in which a first culture medium and a second culture medium were placed in an organ tissue chip equipped with an insert in which cells were cultured. (a) Insert culture plate, (b) Insert culture plate A schematic diagram of inserting the insert in an inverted state, forming a collagen layer on a porous membrane, and attaching and culturing epithelial cells thereon; (c) inserting the insert with cultured epithelial cells into an organ tissue chip and forming a collagen layer on the porous membrane; A schematic diagram showing the state in which endothelial cells are formed and endothelial cells are attached and cultured thereon.
Figure 4 is a 3D schematic diagram of an insert culture plate.
Figure 5 is a photograph of the insert inserted into the insert culture plate. The upper left photo is a photo with the insert placed under the insert culture plate, the upper right photo is a photo with the culture medium (pink liquid) placed in the insert, and the lower photo is a side photo of the insert culture plate with the insert inserted.

Below, the configuration of the present invention will be described in more detail through specific examples. However, it is obvious to those skilled in the art that the scope of the present invention is not limited to the description of the examples.

Device fabrication

The long-term simulation chip according to an embodiment of the present invention includes a substrate, an upper channel pattern layer made of PDMS (Polydimethylsiloxane), a middle separation pattern layer and a lower channel pattern layer, and a chip frame and insert made of PC (Polycarbonate). (Figure 1a, Figure 1b). Using an embossed aluminum metal mold, a PDMS layer (lower channel pattern layer, upper channel pattern layer, and middle separation pattern layer) patterned with microfluidic channels with a width of 0.25 mm and a height of 0.2 mm was fabricated. PDMS was used by mixing Silicone Elastomer Base and Silicone Elastomer Curing Agent (Sylgard 184, K1 solution) in a ratio of 10:1. The top surface of the PDMS in the mold was pushed and made flat. A PET film was placed on the PDMS layer to prevent bubbles from forming. It was covered with a weighted body, fixed on both sides with clips, and hardened by heating in an oven at 80°C for 1 hour. PDMS was removed from the mold, and holes were formed with a bio-punch in the necessary areas.

The PC layer (chip frame) was manufactured by mechanically processing a PC board into a badge chamber into which badges can be placed and an insert chamber into which inserts can be inserted.

Through O ₂ plasma treatment, three layers of PDMS were attached to the glass substrate: the lower channel pattern layer, the middle separation pattern layer, and the upper channel pattern layer.

After attaching double-sided tape to the PC layer (chip frame) to prevent bubbles from forming, holes were formed with a bio-punch in the necessary areas. The double-sided tape on the chip frame was removed and firmly attached to the upper channel pattern layer.

After inserting the O-ring into the insert cell culture chamber, it was treated in an autoclave at 121°C for 5 minutes.

The first culture medium chamber, the second culture medium chamber located at one end of the chip structure, and the first culture medium outlet and second culture medium outlet located at the other end are tilted through the upper fluid channel and the lower fluid channel formed in the PDMS layer by gravity. As the medium flows from the lower chamber to the lower outlet, it flows through the porous membrane of the inserts located between them.

On the side of the insert cell culture chamber, a groove was made into which a screw and an O-ring could be inserted to screw the insert. The insert can also be made of PC material, and the outer side of the insert is also screw-processed so that it can be inserted into a chip. For cell culture, a porous membrane (Polyester Membrane) with a pore diameter of 0.45 μm and a pore density of 3.5x10 ⁶ pores/cm ² is used. filter, It4ip) was attached to the lower part of the insert using epoxy (Resin + hardener, Hi Temp Korea), dried for 24 hours, and then assembled on the chip frame.

Cell culture and culture conditions

Before the epoxy hardened, a thin layer of epoxy was applied on the insert, a porous membrane (0.4 μm, 5.6 mm) was attached, it was hardened for a day, and then autoclaved (121 degrees, 5 minutes).

Collagen 1 (5mg/ml) : NaHCO ₃ : HEPES = 8 : 1 : 1 was mixed to create a collagen solution.

After inserting the insert (1) into the insert cell culture plate (5), spread 5 ul of collagen solution evenly on top of the porous membrane (112) of the insert (1) and place in an incubator (37°C, 5%) for 30 minutes to coat. did.

As a _type ^of endothelial cell, HUVEC (Human Umbilical Vein Endothelial Cells; 3 Cultured in an incubator. As a culture medium A commercially available endothelial cell growth medium was used, and cells with passage numbers 6 to 8 were used in the experiment.

The lower and upper fluid channels of the chip were washed once with PBS and more than once with medium. The upper fluid channel was washed with REGM (Renal epithelial cell growth medium), and the lower fluid channel was washed with EGM2 (Epithelial cell growth medium 2).

The seeded insert (1) was mounted on the plate (5) and cultured for one day. One day later, retrieve the insert (1) from the plate (5), insert it into the chip (2) equipped with the chip's insert coupling portion (26) and O-ring (12), add a little medium to the cell culture chamber (111), and add the lower fluid. EGM2 was added to channel (242). The solution that rose to the top of the insert's porous membrane (112) was removed, and 5 ul of the collagen solution was spread evenly on top of the insert's porous membrane (112) and incubated at 37°C for 30 minutes in 5% CO ₂ .

RPTEC (renal primary tubule epithelail cell, Lonza), a type of epithelial cell, was cultured in an incubator at 5% CO ₂ and 37°C. The culture medium for RPTEC was REGM (REBM 500mL, hEGF 0.5mL, Insulin 0.5mL, Hydrocortisone 0.5mL, GA-1000 0.5%, FBS 2.5mL, Transferrin 0.5mL, Triiodothyronine 0.5mL, Epinephrine 0.5mL), and the passage number was used in the experiment. Approximately 6 to 8 cells were used.

100 ul of RPTEC (3 × 10 ⁶ cells/ml) were added to the insert and cultured for 1 hour. The organ-simulating chip structure was completed by filling the insert with REGM medium and the insert cell culture chamber with each appropriate medium. Cultured on a rocker at 10°, 500 second intervals for 3, 7, and 14 days.

1: Insert 11: Insert structure
111: Insert cell culture chamber 112: Porous separation membrane
12: O-ring 13: Upper fluid channel connection hole
2: Chip 21: Chip Frame
22: upper channel pattern layer 23: middle separation pattern layer
230: second culture medium 231: second culture medium chamber
232: upper fluid channel 233: second culture fluid outlet
24: lower channel pattern layer 240: first culture medium
241: first culture chamber 242: lower fluid channel
243: first culture medium outlet 25: substrate
26: Insert coupling part 3: Flow rate control part
41: Epithelial cell 42: Endothelial cell
5: Insert cell culture plate 51: Culture fluid injection port
52: Insert insertion hole 6: Collagen layer

Claims (9)

In the long-term simulation chip structure,
One or more inserts (1) modules, each with cells cultured; and
Includes a chip capable of inserting and placing the insert (1) module,
The plurality of insert (1) modules are inserted into the chip to form an organ simulation chip,
The organ simulation chip includes an upper fluid channel 232, a lower fluid channel 242, and an upper fluid channel flow rate controller 3 capable of adjusting the cross-sectional area of the upper fluid channel 232,
An organ simulating chip structure in which the organ simulating chip structure is formed by co-culturing the organ simulating chip.
In claim 1,
The long-term simulation chip structure is
A substrate 25, a lower channel pattern layer 24 laminated on the substrate 25, an upper channel pattern layer 22 laminated on the lower channel pattern layer 24, and on the upper channel pattern layer 22. Formed to include a stacked chip frame (21),
First culture medium chamber 241; a second culture chamber (231); One or more insert coupling portions (26) that are downwardly recessed with their upper sides open so that each of the one or more insert (1) modules can be inserted; First culture outlet (243); second culture outlet (233);
The first culture medium chamber 241 to enable movement of the first culture medium 240 between the one or more insert cell culture chambers 111 and the first culture medium outlet 243. It includes a lower fluid channel (242) connecting the one or more insert cell culture chambers (111) and the first culture outlet (243),
The second culture medium chamber 231 to enable movement of the second culture medium 230 between the second culture medium chamber 231 and the one or more insert cell culture chambers 111 and the second culture medium outlet 233. It includes an upper fluid channel (232) connecting the one or more insert cell culture chambers (111) and the second culture outlet (233),
The insert 1 is formed in a vertical direction through the chip frame 21, the upper channel pattern layer 22, and the lower channel pattern layer 24, and an insert cell culture chamber 111 is formed therein. , a porous membrane 112 is formed on one side of the insert cell culture chamber 111, and epithelial cells and endothelial cells are cultured on both surfaces of the porous membrane 112, respectively,
The upper fluid channel flow rate control unit 3 is formed on the chip frame 21 and adjusts the flow rate of the upper fluid channel 232 by adjusting the cross-sectional area of the upper fluid channel 232,
Long-term simulation chip structure.
In claim 1,
The organ simulation chip structure is
(a) one or more inserts (1) that simulate the same type of organ in the module; or
(B) An organ simulation chip structure in which different types of organs are simulated in each of the one or more modules of the insert (1).
In claim 1,
The chip frame 21 is a long-term simulating chip structure formed of an elastic material.
In claim 1,
The upper fluid channel flow rate control unit (3) is a long-term simulating chip structure including a screw, a weight, or an elastic body.
In claim 1,
The lower fluid channel 242 simulates the lumen of an organ,
The upper fluid channel 232 simulates the inside of the organ,
Long-term simulation chip structure.
In claim 1,
The components and amounts of the medium supplied to each of the one or more modules of the insert (1) are individually adjusted in consideration of the culture requirements of each cell cultured in each of the one or more modules of the insert (1). Organ simulation chip structure.
In a method of testing the pharmacokinetic behavior of a test drug using a long-term simulating chip structure,
The organ simulation chip structure is
One or more inserts (1) module in which cells are cultured; and
Includes a chip capable of inserting and placing the insert module,
The insert module is combined with the chip to form an organ simulation chip,
The organ simulation chip includes an upper fluid channel 232, a lower fluid channel 242, and an upper fluid channel flow rate controller 3 capable of adjusting the cross-sectional area of the upper fluid channel 232,
Different fluids flow through the upper fluid channel 232 and the lower fluid channel 242, respectively.
A method for testing the pharmacokinetic behavior of a drug to be tested, characterized in that the upper fluid channel (232) can control the flow rate of the fluid by adjusting the cross-sectional area with the upper fluid channel flow rate control unit (3) according to conditions.
In claim 8,
The organ simulation chip structure is
A substrate 25, a lower channel pattern layer 24 laminated on the substrate 25, an upper channel pattern layer 22 laminated on the lower channel pattern layer 24, and on the upper channel pattern layer 22. Formed to include a stacked chip frame (21),
First culture medium chamber 241; a second culture chamber (231); One or more insert coupling portions (26) that are downwardly recessed with their upper sides open so that each of the one or more insert (1) modules can be inserted; First culture outlet (243); second culture outlet (233);
The first culture medium chamber 241 to enable movement of the first culture medium 240 between the one or more insert cell culture chambers 111 and the first culture medium outlet 243. It includes a lower fluid channel 242 connecting the one or more insert cell culture chambers 111 and the first culture outlet 243,
The second culture medium chamber 231 to enable movement of the second culture medium 230 between the second culture medium chamber 231 and the one or more insert cell culture chambers 111 and the second culture medium outlet 233. It includes an upper fluid channel (232) connecting the one or more insert cell culture chambers (111) and the second culture outlet (233),
The insert 1 is formed in a vertical direction through the chip frame 21, the upper channel pattern layer 22, and the lower channel pattern layer 24, and an insert cell culture chamber 111 is formed therein. , a porous membrane 112 is formed on one side of the insert cell culture chamber 111, and epithelial cells and endothelial cells are cultured on both surfaces of the porous membrane 112, respectively,
The upper fluid channel flow rate control unit 3 is formed on the chip frame 21 and controls the flow rate of the upper fluid channel 232 by adjusting the cross-sectional area of the upper fluid channel 232. Methods for testing pharmacokinetic behavior.